Title: 26839 Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks
Abstract: Background: Atopic dermatitis (AD) affects different anatomic regions; some adults may exhibit more localized AD, such as head and neck involvement. We analyzed the extent of improvement in AD signs across different anatomic regions at Week 52 using data from the phase 3 dupilumab trial, LIBERTY AD CHRONOS (NCT02260986).
Publication Year: 2021
Publication Date: 2021-08-07
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot